Home
Login Register
Venture    Last:17.47    -0.02

Venture

 Post Reply 121-140 of 4972
 
tongphlp
    17-Nov-2021 13:49  
Contact    Quote!
18 soon...
 
 
tongphlp
    17-Nov-2021 13:47  
Contact    Quote!
From the price movements, obvious PMI is not giving a cent to Venture..

tongphlp      ( Date: 17-Nov-2021 11:39) Posted:

PMI to Commit Additional USD 200 Million to Corporate Venture Capital Activities of PM Equity Partner

October 28, 2021 05:59 AM Eastern Daylight Time


LAUSANNE, Switzerland--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced its plans to dedicate a further USD 200 million to minority investments in early and growth-stage companies through PM Equity Partner (PMEP), PMI&rsquo s corporate venture capital arm. This allocation follows a 2016 commitment of USD 150 million that PMEP has since fully invested and is intended to support PMI&rsquo s smoke-free and beyond nicotine ambitions.

With this latest round of funding, PMI will leverage its strengths to help investee companies translate innovation into commercial success. Developed through PMI&rsquo s journey to replace cigarettes with smoke-free alternatives, the company&rsquo s best-in-class capabilities include advanced life science expertise, preclinical and clinical research, and aerosolization.

PMEP is focusing its investment activities on four distinct technology segments:
  1. Life science innovations, such as inhaled therapeutics and computational research methodologies.
  2. Industrial technologies like industrial robotics and automation, the internet of things, and technology-based process optimization.
  3. Product technologies, particularly those that relate to inhalation and aerosolization, chemical formulation, and bio-authentication.
  4. Consumer engagement technologies, such as user identification and age authentication, innovative customer care, and experience management.


Emmanuel Babeau, PMI&rsquo s Chief Financial Officer, said: &ldquo PMI&rsquo s scientific and technological leadership has enabled us to re-invent our company in our pursuit to unsmoke the world. We are dedicating further funds to our venture capital arm at a moment when we are in an even stronger position to leverage our expertise to support the development and commercialization of cutting-edge technologies, to the benefit of both PMI and investee companies.&rdquo

Alexander Stoeckel, head of PMEP, added: &ldquo PMEP is looking to invest in companies that can help PMI accelerate and further sophisticate our transformation while we support them through our industry-leading expertise to mature their technologies and businesses. We see this exchange as a win-win for PMI, the companies we invest in, and society.&rdquo

PMEP has a track record of success with investments in 13 companies to date through its 2016 funding commitment. Ideal investments are between USD 2 to 10 million in Series A stage companies, with flexibility to also consider investments in seed or late-growth stage companies. PMEP investments are intended to add to our potential to innovate, while better positioning our partner companies for success.

PMI is leading the transformation of the industry in our pursuit to go smoke-free. Since 2008, we have invested more than USD 8.1 billion into the science and research of developing smoke-free products, employing hundreds of world-class scientists, engineers, and technicians in our R& D efforts. Our pre-clinical and clinical programs are inspired by the pharmaceutical industry and aligned with internationally recognized good practices, with more than 425 peer-reviewed publications and book chapters published since 2008. In July 2020, PMI was the second company to receive authorization from the U.S. FDA to market a nicotine or tobacco product as a modified risk tobacco product, with the agency concluding that issuing exposure modification orders for our heated tobacco system  IQOS  is &ldquo appropriate to promote the public health&rdquo and is &ldquo expected to benefit the health of the population as a whole.&rdquo Today, 29% of our total net revenues are derived from smoke-free products, and approximately 14.9 million adult smokers have switched to  IQOS  and stopped smoking.

More details on PMEP, its investment strategy, criteria, team, and how to be in touch can be found at  www.pmequitypartner.com.

https://www.businesswire.com/news/home/20211028005205/en/PMI-to-Commit-Additional-USD-200-Million-to-Corporate-Venture-Capital-Activities-of-PM-Equity-Partner

 
 
tongphlp
    17-Nov-2021 11:39  
Contact    Quote!

PMI to Commit Additional USD 200 Million to Corporate Venture Capital Activities of PM Equity Partner

October 28, 2021 05:59 AM Eastern Daylight Time


LAUSANNE, Switzerland--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced its plans to dedicate a further USD 200 million to minority investments in early and growth-stage companies through PM Equity Partner (PMEP), PMI&rsquo s corporate venture capital arm. This allocation follows a 2016 commitment of USD 150 million that PMEP has since fully invested and is intended to support PMI&rsquo s smoke-free and beyond nicotine ambitions.

With this latest round of funding, PMI will leverage its strengths to help investee companies translate innovation into commercial success. Developed through PMI&rsquo s journey to replace cigarettes with smoke-free alternatives, the company&rsquo s best-in-class capabilities include advanced life science expertise, preclinical and clinical research, and aerosolization.

PMEP is focusing its investment activities on four distinct technology segments:
  1. Life science innovations, such as inhaled therapeutics and computational research methodologies.
  2. Industrial technologies like industrial robotics and automation, the internet of things, and technology-based process optimization.
  3. Product technologies, particularly those that relate to inhalation and aerosolization, chemical formulation, and bio-authentication.
  4. Consumer engagement technologies, such as user identification and age authentication, innovative customer care, and experience management.


Emmanuel Babeau, PMI&rsquo s Chief Financial Officer, said: &ldquo PMI&rsquo s scientific and technological leadership has enabled us to re-invent our company in our pursuit to unsmoke the world. We are dedicating further funds to our venture capital arm at a moment when we are in an even stronger position to leverage our expertise to support the development and commercialization of cutting-edge technologies, to the benefit of both PMI and investee companies.&rdquo

Alexander Stoeckel, head of PMEP, added: &ldquo PMEP is looking to invest in companies that can help PMI accelerate and further sophisticate our transformation while we support them through our industry-leading expertise to mature their technologies and businesses. We see this exchange as a win-win for PMI, the companies we invest in, and society.&rdquo

PMEP has a track record of success with investments in 13 companies to date through its 2016 funding commitment. Ideal investments are between USD 2 to 10 million in Series A stage companies, with flexibility to also consider investments in seed or late-growth stage companies. PMEP investments are intended to add to our potential to innovate, while better positioning our partner companies for success.

PMI is leading the transformation of the industry in our pursuit to go smoke-free. Since 2008, we have invested more than USD 8.1 billion into the science and research of developing smoke-free products, employing hundreds of world-class scientists, engineers, and technicians in our R& D efforts. Our pre-clinical and clinical programs are inspired by the pharmaceutical industry and aligned with internationally recognized good practices, with more than 425 peer-reviewed publications and book chapters published since 2008. In July 2020, PMI was the second company to receive authorization from the U.S. FDA to market a nicotine or tobacco product as a modified risk tobacco product, with the agency concluding that issuing exposure modification orders for our heated tobacco system  IQOS  is &ldquo appropriate to promote the public health&rdquo and is &ldquo expected to benefit the health of the population as a whole.&rdquo Today, 29% of our total net revenues are derived from smoke-free products, and approximately 14.9 million adult smokers have switched to  IQOS  and stopped smoking.

More details on PMEP, its investment strategy, criteria, team, and how to be in touch can be found at  www.pmequitypartner.com.

https://www.businesswire.com/news/home/20211028005205/en/PMI-to-Commit-Additional-USD-200-Million-to-Corporate-Venture-Capital-Activities-of-PM-Equity-Partner
 

 
tongphlp
    17-Nov-2021 11:07  
Contact    Quote!
wonder who bought at 19.27 at opening? Licking their wounds now..
 
 
tongphlp
    17-Nov-2021 10:26  
Contact    Quote!
Hopeless and directionless

tongphlp      ( Date: 15-Nov-2021 14:35) Posted:

56k lots q to get out at 19.2..
 
5,000 18.800 19.170 10,800
2,000 18.770 19.180 11,400
2,400 18.750 19.190 14,200
1,000 18.710 19.200 56,500


tongphlp      ( Date: 15-Nov-2021 13:02) Posted:

Giving up early gains as usual. Not surprise if investors are shorting it


 
 
tongphlp
    16-Nov-2021 10:52  
Contact    Quote!
 

 
tongphlp
    16-Nov-2021 10:42  
Contact    Quote!

Philip Morris International Inc. (NYSE:PM) insiders sold US$14m worth of stock, possibly signalling a downtrend

By
Simply Wall St
Published
November 15, 2021

https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-pm/philip-morris-international/news/philip-morris-international-inc-nysepm-insiders-sold-us14m-w
 
 
tongphlp
    15-Nov-2021 15:20  
Contact    Quote!

PPhilip Morris International pushes FDA on Iqos imports

NoNov. 09, 2021 8:45 AM ETPhilip Morris International Inc. (PM)MOBy: Clark SchultzSA News Editor34 Comments

https://seekingalpha.com/news/3767676-philip-morris-international-pushes-fda-on-iqos-imports
 
 
tongphlp
    15-Nov-2021 15:17  
Contact    Quote!

Will Philip Morris fulfill pledge to be ' majority smoke-free' in Connecticut?

 
Nov. 14, 2021Updated: Nov. 14, 2021 10:57  p.m.

https://www.ctinsider.com/business/article/Will-Philip-Morris-fulfill-pledge-to-be-16619677.php
 
 
tongphlp
    15-Nov-2021 14:35  
Contact    Quote!
56k lots q to get out at 19.2..
 
5,000 18.800 19.170 10,800
2,000 18.770 19.180 11,400
2,400 18.750 19.190 14,200
1,000 18.710 19.200 56,500


tongphlp      ( Date: 15-Nov-2021 13:02) Posted:

Giving up early gains as usual. Not surprise if investors are shorting it.

Joelton      ( Date: 15-Nov-2021 09:06) Posted:

Venture Corporation
 
On Nov 8, Venture Corporation Venture: V03 +3.36% (Venture) executive chairman Wong Ngit Liong acquired 200,000 shares of the company at an average price of S$18.73 per share. With a consideration of S$3,745,600, this took his direct interest in Venture from 7.04 per cent to 7.11 per cent.
 
His preceding acquisition of Venture shares via market transactions were back in 2017 with 400,000 shares of Venture purchased at S$15.26 per share in September and 271,600 shares purchased at S$12.51 per share in July of that year.
 
The acquisitions in July 2017 and November 2021 were both conducted when Venture was trading at an 18x earnings multiple.
 
Wong has been the recipient of many awards for his business acumen and services to the industry and has been instrumental in the growth of Venture since its beginnings as a startup in the electronics manufacturing services business in the early 1980s.
 
On Nov 5, Venture announced that Wong will step down from his chief executive officer position on Jan 1, 2022 but will remain as the executive chairman of the board. The current chief operating officer Lee Ghai Keen will take Wong' s place as chief executive officer.
 
As noted on Nov 3, in its Q3FY21 (ended Sep 30) business update, for the next 12 months, Venture expects several new products to be launched into global markets, including products uniquely emanating from its R& D Labs and manufacturing sites.
 
The group noted that it is also seeing strong trends in new product introductions activities, which are expected to flow through to mass production at its manufacturing sites over the next 12 months.
 
With Venture maintaining that it is at a crucial stage in its strategic evolution, it has also established two panels comprising specialists in selected fields to support the group' s strategic directions. The panel of experts constitutes distinguished scientists and engineers with eminent qualifications and high professional standing in selected fields of expertise to provide guidance to the group' s R& D initiatives.
 
The panel of advisers will support the company' s investment committee on business planning and strategic initiatives to, among other things, evaluate viable investments in diverse portfolios.


 

 
tongphlp
    15-Nov-2021 13:13  
Contact    Quote!
Analysts say BUY so retailers would do so and they can sell to them? Don' t see any heavy buying though they put BUY calls..

tongphlp      ( Date: 13-Nov-2021 06:08) Posted:

Maybe due to analysts upgrade?

Preview Image

Fiat500      ( Date: 12-Nov-2021 16:44) Posted:

Any idea why the sudden surge in Venture today? Have not seen such gains in a single day for Venture since I couldn't remember how long ago !


 
 
tongphlp
    15-Nov-2021 13:02  
Contact    Quote!
Giving up early gains as usual. Not surprise if investors are shorting it.

Joelton      ( Date: 15-Nov-2021 09:06) Posted:

Venture Corporation
 
On Nov 8, Venture Corporation Venture: V03 +3.36% (Venture) executive chairman Wong Ngit Liong acquired 200,000 shares of the company at an average price of S$18.73 per share. With a consideration of S$3,745,600, this took his direct interest in Venture from 7.04 per cent to 7.11 per cent.
 
His preceding acquisition of Venture shares via market transactions were back in 2017 with 400,000 shares of Venture purchased at S$15.26 per share in September and 271,600 shares purchased at S$12.51 per share in July of that year.
 
The acquisitions in July 2017 and November 2021 were both conducted when Venture was trading at an 18x earnings multiple.
 
Wong has been the recipient of many awards for his business acumen and services to the industry and has been instrumental in the growth of Venture since its beginnings as a startup in the electronics manufacturing services business in the early 1980s.
 
On Nov 5, Venture announced that Wong will step down from his chief executive officer position on Jan 1, 2022 but will remain as the executive chairman of the board. The current chief operating officer Lee Ghai Keen will take Wong' s place as chief executive officer.
 
As noted on Nov 3, in its Q3FY21 (ended Sep 30) business update, for the next 12 months, Venture expects several new products to be launched into global markets, including products uniquely emanating from its R& D Labs and manufacturing sites.
 
The group noted that it is also seeing strong trends in new product introductions activities, which are expected to flow through to mass production at its manufacturing sites over the next 12 months.
 
With Venture maintaining that it is at a crucial stage in its strategic evolution, it has also established two panels comprising specialists in selected fields to support the group' s strategic directions. The panel of experts constitutes distinguished scientists and engineers with eminent qualifications and high professional standing in selected fields of expertise to provide guidance to the group' s R& D initiatives.
 
The panel of advisers will support the company' s investment committee on business planning and strategic initiatives to, among other things, evaluate viable investments in diverse portfolios.

 
 
tongphlp
    15-Nov-2021 09:43  
Contact    Quote!
With his wealth, Wong should be acquiring 2m shares! Why 200k? To mitigate the decrease in Blackrock shareholdings?

Joelton      ( Date: 15-Nov-2021 09:06) Posted:

Venture Corporation
 
On Nov 8, Venture Corporation Venture: V03 +3.36% (Venture) executive chairman Wong Ngit Liong acquired 200,000 shares of the company at an average price of S$18.73 per share. With a consideration of S$3,745,600, this took his direct interest in Venture from 7.04 per cent to 7.11 per cent.
 
His preceding acquisition of Venture shares via market transactions were back in 2017 with 400,000 shares of Venture purchased at S$15.26 per share in September and 271,600 shares purchased at S$12.51 per share in July of that year.
 
The acquisitions in July 2017 and November 2021 were both conducted when Venture was trading at an 18x earnings multiple.
 
Wong has been the recipient of many awards for his business acumen and services to the industry and has been instrumental in the growth of Venture since its beginnings as a startup in the electronics manufacturing services business in the early 1980s.
 
On Nov 5, Venture announced that Wong will step down from his chief executive officer position on Jan 1, 2022 but will remain as the executive chairman of the board. The current chief operating officer Lee Ghai Keen will take Wong' s place as chief executive officer.
 
As noted on Nov 3, in its Q3FY21 (ended Sep 30) business update, for the next 12 months, Venture expects several new products to be launched into global markets, including products uniquely emanating from its R& D Labs and manufacturing sites.
 
The group noted that it is also seeing strong trends in new product introductions activities, which are expected to flow through to mass production at its manufacturing sites over the next 12 months.
 
With Venture maintaining that it is at a crucial stage in its strategic evolution, it has also established two panels comprising specialists in selected fields to support the group' s strategic directions. The panel of experts constitutes distinguished scientists and engineers with eminent qualifications and high professional standing in selected fields of expertise to provide guidance to the group' s R& D initiatives.
 
The panel of advisers will support the company' s investment committee on business planning and strategic initiatives to, among other things, evaluate viable investments in diverse portfolios.

 
 
Joelton
    15-Nov-2021 09:06  
Contact    Quote!
Venture Corporation
 
On Nov 8, Venture Corporation Venture: V03 +3.36% (Venture) executive chairman Wong Ngit Liong acquired 200,000 shares of the company at an average price of S$18.73 per share. With a consideration of S$3,745,600, this took his direct interest in Venture from 7.04 per cent to 7.11 per cent.
 
His preceding acquisition of Venture shares via market transactions were back in 2017 with 400,000 shares of Venture purchased at S$15.26 per share in September and 271,600 shares purchased at S$12.51 per share in July of that year.
 
The acquisitions in July 2017 and November 2021 were both conducted when Venture was trading at an 18x earnings multiple.
 
Wong has been the recipient of many awards for his business acumen and services to the industry and has been instrumental in the growth of Venture since its beginnings as a startup in the electronics manufacturing services business in the early 1980s.
 
On Nov 5, Venture announced that Wong will step down from his chief executive officer position on Jan 1, 2022 but will remain as the executive chairman of the board. The current chief operating officer Lee Ghai Keen will take Wong' s place as chief executive officer.
 
As noted on Nov 3, in its Q3FY21 (ended Sep 30) business update, for the next 12 months, Venture expects several new products to be launched into global markets, including products uniquely emanating from its R& D Labs and manufacturing sites.
 
The group noted that it is also seeing strong trends in new product introductions activities, which are expected to flow through to mass production at its manufacturing sites over the next 12 months.
 
With Venture maintaining that it is at a crucial stage in its strategic evolution, it has also established two panels comprising specialists in selected fields to support the group' s strategic directions. The panel of experts constitutes distinguished scientists and engineers with eminent qualifications and high professional standing in selected fields of expertise to provide guidance to the group' s R& D initiatives.
 
The panel of advisers will support the company' s investment committee on business planning and strategic initiatives to, among other things, evaluate viable investments in diverse portfolios.
 
 
tongphlp
    15-Nov-2021 08:44  
Contact    Quote!
no more opening by up 70c? 

Fiat500      ( Date: 12-Nov-2021 16:44) Posted:

Any idea why the sudden surge in Venture today? Have not seen such gains in a single day for Venture since I couldn't remember how long ago !

 

 
tongphlp
    15-Nov-2021 06:21  
Contact    Quote!
https://links.sgx.com/1.0.0/corporate-announcements/1JDKI3TC2RT3YFK7/61ee7a02f8b8dfcb6d8e25160a896264598f4cb91ff95ed86ee6b38b4b2edbf6

Blackrock shareholdings in Venture decreased..
 
 
tongphlp
    13-Nov-2021 06:08  
Contact    Quote!
Maybe due to analysts upgrade?

Preview Image

Fiat500      ( Date: 12-Nov-2021 16:44) Posted:

Any idea why the sudden surge in Venture today? Have not seen such gains in a single day for Venture since I couldn't remember how long ago !

 
 
tongphlp
    12-Nov-2021 19:18  
Contact    Quote!
You are right! I am puzzled too! No reason for it to head up!

Fiat500      ( Date: 12-Nov-2021 16:44) Posted:

Any idea why the sudden surge in Venture today? Have not seen such gains in a single day for Venture since I couldn't remember how long ago !

 
 
Fiat500
    12-Nov-2021 16:44  
Contact    Quote!
Any idea why the sudden surge in Venture today? Have not seen such gains in a single day for Venture since I couldn't remember how long ago !
 
 
tongphlp
    12-Nov-2021 16:24  
Contact    Quote!
No lah..ah WONG decided he needs to replace his RR...so need to sell some shares..when WONG speaks, everyone obeys! :)

nott1965      ( Date: 12-Nov-2021 16:22) Posted:

Today so aggressive buying seen, suspect it is share buyback as deeply undervalued

 
Important: Please read our Terms and Conditions and Privacy Policy .